Paper659409
Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA.
McGarry JD and 2 others. J Biol Chem, 1978. Cited by 550 papers, by iCite.
Cite this record
ConductScience Library. Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. Papers, record 659409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/659409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acyl Coenzyme A | Major topic |
| Acyltransferases | Major topic |
| Carnitine O-Palmitoyltransferase | Major topic |
| Fatty Acids | Major topic |
| Malonyl Coenzyme A | Major topic |
| Mitochondria, Liver | Major topic |
| Animals | |
| Coenzyme A | |
| Kinetics | |
| Male | |
| Rats |
Source PubMed
Cited by194
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 550 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42728345 | Propionyl-CoA catabolism is a metabolic gatekeeper for fatty acid oxidation in pancreatic cancer. | Oncogene | 2026 | https://conductscience.org/library/papers/42728345 | PubMed |
| 42627907 | A multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders. | Sci Adv | 2026 | https://conductscience.org/library/papers/42627907 | PubMed |
| 42597308 | The emerging metabolic role and treatment target of CPT1A in CRC. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42597308 | PubMed |
| 42183273 | Hyperglycemia- induced innate immune tolerance involves the metabolic and epigenetic rewiring in human alveolar macrophages. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183273 | PubMed |
| 42151205 | Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial. | Sci Rep | 2026 | https://conductscience.org/library/papers/42151205 | PubMed |
| 41462053 | Synteny - a high throughput web tool to streamline causal gene prioritisation and provide insight into protein function. | Sci Rep | 2025 | https://conductscience.org/library/papers/41462053 | PubMed |
| 41390753 | Advanced glycation end products exacerbate lipopolysaccharide-induced acute lung injury with diabetes by promoting ferroptosis via AMP-activated protein kinase/acetyl-CoA carboxylase signaling. | Sci Rep | 2025 | https://conductscience.org/library/papers/41390753 | PubMed |
| 41372486 | Neuronal fatty acid oxidation fuels memory after intensive learning in Drosophila. | Nat Metab | 2025 | https://conductscience.org/library/papers/41372486 | PubMed |
| 41309601 | Acetyl-CoA carboxylase maintains energetic balance for functional oogenesis. | Nat Commun | 2025 | https://conductscience.org/library/papers/41309601 | PubMed |
| 41238906 | Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency. | Nat Metab | 2025 | https://conductscience.org/library/papers/41238906 | PubMed |
| 41044057 | MTCH2 modulates CPT1 activity to regulate lipid metabolism of adipocytes. | Nat Commun | 2025 | https://conductscience.org/library/papers/41044057 | PubMed |
| 41003805 | The role of succinylation-mediated metabolic reprogramming in tumor progression. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/41003805 | PubMed |
| 39588271 | Molecular mechanisms of lipid droplets-mitochondria coupling in obesity and metabolic syndrome: insights and pharmacological implications. | Front Physiol | 2024 | https://conductscience.org/library/papers/39588271 | PubMed |
| 39453987 | Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond. | Cardiovasc Res | 2024 | https://conductscience.org/library/papers/39453987 | PubMed |
| 39335940 | The Herbal Blend of Sphaeranthus indicus and Garcinia mangostana Reduces Adiposity in High-Fat Diet Obese Mice. | Foods | 2024 | https://conductscience.org/library/papers/39335940 | PubMed |
| 38988566 | Lomitapide repurposing for treatment of malignancies: A promising direction. | Heliyon | 2024 | https://conductscience.org/library/papers/38988566 | PubMed |
| 38635138 | The α subunit of AMP-activated protein kinase is critical for the metabolic success and tachyzoite proliferation of Toxoplasma gondii. | Microb Biotechnol | 2024 | https://conductscience.org/library/papers/38635138 | PubMed |
| 38500157 | The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications. | J Transl Med | 2024 | https://conductscience.org/library/papers/38500157 | PubMed |
| 38495496 | Unveiling the STAT3-ACC1 axis: a key driver of lipid metabolism and tumor progression in non-small cell lung cancer. | J Cancer | 2024 | https://conductscience.org/library/papers/38495496 | PubMed |
| 38368351 | Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease. | Lipids Health Dis | 2024 | https://conductscience.org/library/papers/38368351 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/659409
GET https://conductscience.org/api/papers/v1/659409/cited_by?page=2